Differential gene expression in response to adjunctive recombinant human interleukin-2 immunotherapy in multidrug-resistant tuberculosis patients

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2426-2433

  Johnson, Barbara J ^a   Estrada, Iris ^b,d   Shen, Zhu ^a   Ress, Stan ^c   Willcox, Paul ^c   Colston, M Joseph ^b   Kaplan, Gilla ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADAPTIN; CD63 ANTIGEN; CELL PROTEIN; CLATHRIN; CLOFAZIMINE; CYTOCHROME C OXIDASE; CYTOKINE; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; INTERLEUKIN 2; ISONIAZID; KANAMYCIN; MESSENGER RNA; MYCOBACTERIUM ANTIGEN; OFLOXACIN; PLACEBO; PYRAZINAMIDE; RECOMBINANT INTERLEUKIN 2; RIBONUCLEOPROTEIN; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TERIZIDONE; THIOACETAZONE; TUBERCULIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INTRADERMAL DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 0031839516     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2426-2433.1998     Document Type: Article

References (41)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489.
3. Bauer, D., H. Muller, J. Reich, H. Riedel, V. Ahrenkiel, P. Warthoe, and M. Strauss. 1993. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res. 21:4272-4280.
4. Brennan, P. J. 1989. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. J. Infect. Dis. 11:S420-S430.
5. Brown, G. C. 1995. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:136-139.
6. Chakrabarti, R., M. Joly, and S. Corvera. 1993. Redistribution of clathrincoated vesicle adaptor complexes during adipocytic differentiation of 3T3-L1 cells. J. Cell Biol. 123:79-87.
7. Chan, J., X.-D. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-1761.
8. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
9. Clemens, D. L., and M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:257-270.
10. Cohn, D. L. 1995. Treatment of multidrug-resistant tuberculosis. J. Hosp. Infect. 30:322-328.
11. Denis, M. 1991. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157.
12. Flesch, I. E. A., and S. H. E. Kaufmann. 1987. Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138: 4408-4413.
13. Flesch, I. E. A., and S. H. E. Kaufmann. 1988. Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages. Infect. Immun. 56:1464-1469.
14. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
15. George, R. B., R. L. Penn, and G. T. Kinasewitz. 1985. Mycobacterial, fungal, actinomycotic, and nocardial infections of the pleura. Clin. Chest Med. 6:63-75.
16. Hamilton, T. A., D. L. Becton, S. D. Somers, P. W. Gray, and D. O. Adams. 1984. Interferon-γ modulates protein kinase C activity in murine peritoneal macrophages. J. Biol. Chem. 260:1378-1381.
17. Hamilton, T. A., and D. O, Adams. 1987. Molecular mechanisms of signal transduction in macrophages. Immunol. Today 8:151-158.
18. Hillier, L., N. Clark, T. Dubuque, K. Elliston, M. Hawkins, M. Holman, M. Hultman, T. Kucaba, M. Le, G. Lennon, M. Marra, J. Parsons, L. Rifkin, T. Rohlfing, M. Soares, F. Tan, E. Trevaskis, R. Waterston, A. Williamson, P. Wohldmann, and R. Wilson. 1995. The WashU-Merck EST Project. Unpublished.
19. Hotta, H., H. Miyamoto, I. Hara, N. Takahashi, and M. Homma. 1992. Genomic structure of the ME491/CD63 antigen gene and functional analysis of the 5′-flanking regulatory sequences. Biochem. Biophys. Res. Commun. 185:436-442.
20. Johnson, B. J., and D. N. McMurray. 1994. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 62:1444-1450.
21. Johnson, B. J., S. R. Ress, P. Willcox, B. P. Pati, F. Lorgat, P. Stead, R. Saha, P. Lukey, P. Laochumroonvorapong, L. Corral, and G. Kaplan. 1995. Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy. Cytokines Mol. Ther. 1:185-196.
22. Johnson, B. J., L.-G. Bekker, R. Rickman, S. Brown, M. Lessor, S. Ress, P. Willcox, L. Steyn, and G. Kaplan. rhuIL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimes and placebo. Tubercle Lung Dis., in press.
23. 7) receptors. Immunity 7:433-444.
24. Liang, P., L. Averboukh, and A. B. Pardee. 1993. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res. 21:3269-3275.
25. Liang, P., D. Bauer, L. Averboukh, P. Warthoe, M. Rohrwild, H. Muller, M. Strauss, and A. B. Pardee. 1995. Analysis of altered gene expression by differential display. Methods Enzymol. 254:304-321.
26. Mathieu-Daud, F., R. Cheng, J. Welsh, and M. McClelland. 1996. Screening of differentially amplified cDNA products from RNA arbitrarily primed PCR fingerprints using single strand conformation polymorphism (SSCP) gels. Nucleic Acids Res. 24:1504-1507.
27. Molloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular Mycobacterium bovis Bacillus Calmette-Guerin (BCG). J. Exp. Med. 180: 1499-1509.
28. Mou, L., H. Miller, J. Li, E. Wang, and L. Chalifour. 1994. Improvements to the differential display method for gene analysis. Biochem. Biophys. Res. Commun. 199:564-569.
29. Nomura, N. Submitted (11 Nov 1992) to the DDBJ/EMBL/GenBank databases. Nobuo Nomura, Kazusa DNA Research Institute, Gene Structure I; 1532-3 Yana, Kisarazu, Chiba 292, Japan.
30. Nussler, A., M. DiSilvio, T. R. Billiar, R. A. Hoffman, D. A. Geller, R. Selby, J. Madariaga, and R. L. Simmons. 1992. Stimulation of nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:261-266.
31. Page, L. J., and M. S. Robinson. 1995. Targeting signals and subunit interactions in coated vesicle adaptor complexes. J. Cell Biol. 131:619-630.
32. Ponnambalam, S., M. S. Robinson, A. P. Jackson, L. Peiperl, and P. Parham. 1990. Conservation and diversity in families of coated vesicle adaptins. J. Biol. Chem. 265:4814-4820.
33. Rook, G. A. W., J. Steele, M. Ainsworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma Interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333-338.
34. Sambrook, J., E. F. Fritsch, and T, Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Sanger, F., A. R. Coulson, B. G. Barrell, A. J. Smith, and B. A. Roe. 1980. Cloning in single-stranded bacteriophage as an aid to rapid DNA setquencing. J. Mol. Biol. 143:161-178.
36. Smith, K. A. 1984. Interleukin-2. Annu. Rev. Immunol. 2:319-333.
37. Soulard, M. M., V. V. Della Valle, M. M. Siomi, S. S. Pinol-Roma, P. P. Codogno, C. C. Bauvy, M. M. Belli, J. J. Lacroix, G. G. Monod, G. G. Dreyfuss, and C. C. Larsen. 1993. hnRNPG: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res. 21:4210-4217.
38. Turett, G. S., E. E. Telzak, L. V. Torian, S. Blum, D. Alland, I. Weisfuse, and B. A. Fazal. 1995. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin. Infect. Dis. 21:1238-1244.
39. Weening, R. S., A. de Klein, M. de Boer, and D. Roos. 1996. Effect of interferon-gamma, in vitro and in vivo, on mRNA levels of phagocyte oxidase components. J. Leukocyte Biol. 60:716-720.
40. Xie, Q. W., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by Interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
41. Yamamura, M., K. Uyemura, R. J. Deans, K. Weinberg, T. H. Rea, B. R. Bloom, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254:277-279.